Bin Zhang

Medicine & Life Sciences

1. Neoplasms 100%
2. T-Lymphocytes 81%
3. Immunotherapy 57%
4. Melanoma 54%
5. Esophageal Squamous Cell Carcinoma 45%
6. Immunity 41%
7. Myeloid-Derived Suppressor Cells 36%
8. Interleukin-33 34%
9. Regulatory T-Lymphocytes 32%
10. Interleukin-18 29%
11. Nevus 28%
12. Tumor Microenvironment 24%
13. Non-Small Cell Lung Carcinoma 23%
14. Malignant Pleural Effusion 23%
15. Dendritic Cells 23%
16. Growth 22%
17. Antigens 21%
18. Glioblastoma 20%
19. Nucleic Acids 19%
20. Therapeutics 16%
21. Mutation 16%
22. Myeloid Cells 16%
23. Natural Killer Cells 16%
24. Ovarian Neoplasms 15%
25. Panax 15%
26. Immunosuppressive Agents 15%
27. Macrophages 14%
28. B-Lymphocytes 14%
29. Survival 14%
30. Lung Neoplasms 13%
31. Metformin 13%
32. Dermoscopy 13%
33. Genetically Modified Plants 13%
34. Cytokine-Induced Killer Cells 12%
35. Leukemia 12%
36. High-Throughput Nucleotide Sequencing 12%
37. Neoplasm Metastasis 12%
38. Biomarkers 12%
39. Melanocytes 12%
40. Drug Therapy 12%
41. Neoplasm Antibodies 11%
42. Ligands 11%
43. Immunosuppression 11%
44. HMGB1 Protein 11%
45. Phosphorylation 10%
46. Ubiquitin-Protein Ligases 10%
47. Lymphocytes 10%
48. Cell Proliferation 10%
49. Ginsenosides 10%
50. Epithelioid and Spindle Cell Nevus 10%